Search results for "Materia Medica"

showing 10 items of 121 documents

Effects of Scrophularia ningpoensis Hemsl. on Inhibition of Proliferation, Apoptosis Induction and NF-κB Signaling of Immortalized and Cancer Cell Li…

2012

Scrophularia ningpoensis has been used in China for centuries as a herbal tea to treat various diseases. Based on the numerous animal studies on its pharmaceutical effects and the long time clinical experiences, we studied the molecular and cellular mechanism underlying the bioactivity of aqueous extract of Scrophularia and its isolated compounds. Seven isolated compounds, unlike Scrophularia extract, failed to induce cytotoxicity on HaCaT cells, but their combination improved the effect of extract. Tumor cell line selectivity was not observed, when we studied its cytotoxic effect on melanoma cell lines. The apoptotic and anti-inflammatory effects of Scrophularia extract have been demonstra…

MAPK/ERK pathwaypharmacognosylcsh:Medicinelcsh:RS1-441Pharmaceutical SciencePharmacologyapoptosis; microarrays; pharmacogenomics; pharmacognosy; phytotherapy; signaling pathwaysArticlelcsh:Pharmacy and materia medicaDrug DiscoveryMedicineScrophulariaCytotoxicitymicroarrayspharmacogenomicsScrophularia ningpoensisbiologybusiness.industrylcsh:Rapoptosisphytotherapybiology.organism_classificationsignaling pathwaysHaCaTMechanism of actionApoptosisMolecular MedicineSignal transductionmedicine.symptombusinessPharmaceuticals
researchProduct

Influence of Inter- and Intra-Batch Variability on the Sample Size Required for Demonstration of Equivalent Microstructure of Semisolid Dosage Forms

2020

Inter- and intra-batch variability of the quality attributes contribute to the uncertainty for demonstrating equivalent microstructure of post-approval changes and generic/hybrids of semisolid topical products. Selecting a representative sample size to describe accurately the in vitro properties of semisolids and to reach enough statistical power to demonstrate similarity between two semisolid topical products is currently challenging. The objective of this work is to establish the number of batches and units per batch to be compared based on different inter-batch and intra-batch variability to demonstrate equivalence in the physical characteristics of the products that ensure a similar mic…

Manufacturing processlcsh:RS1-441Pharmaceutical ScienceMicrostructureEquivalenceArticleStatistical powerDosage formIntra-batch variabilitylcsh:Pharmacy and materia medicaSample size determinationInter-batch variabilityBiological systemTopical productsMathematicsPharmaceutics
researchProduct

Densely PEGylated polybenzofulvene brushes for potential applications in drug encapsulation

2018

The technique of grafting side chains onto a linear polymeric backbone is commonly used to confer to the new polymeric material with desired properties, such as tunable solubility, ionic charge, biocompatibility, or specific interactions with biological systems. In this paper, two new polybenzofulvene backbones were assembled by spontaneous polymerization of the appropriate benzofulvene monomers (4,6-PO-BF3k and 4&rsquo

Materials scienceBiocompatibilityDrug delivery systemlcsh:RS1-441Pharmaceutical ScienceNanotechnology02 engineering and technology010402 general chemistry01 natural sciencesArticlelcsh:Pharmacy and materia medicachemistry.chemical_compounddrug delivery systemsAffinity polymerization; Drug delivery systems; Grafting onto; Nanocarrier; PEGylation; Polybenzofulvene; Spontaneous polymerization;grafting ontoSide chainaffinity polymerizationPEGylation021001 nanoscience & nanotechnologyGrafting0104 chemical sciencesMonomerchemistryPolymerizationspontaneous polymerizationPEGylationnanocarrierNanocarriersPolybenzofulvene0210 nano-technologypolybenzofulvene;Ethylene glycol
researchProduct

Engineering of Nanofibrous Amorphous and Crystalline Solid Dispersions for Oral Drug Delivery

2018

Poor aqueous solubility (<0.1 mg/mL) affects a significant number of drugs currently on the market or under development. Several formulation strategies including salt formation, particle size reduction, and solid dispersion approaches have been employed with varied success. In this review, we focus primarily on the emerging trends in the generation of amorphous and micro/nano-crystalline solid dispersions using electrospinning to improve the dissolution rate and in turn the bioavailability of poorly water-soluble drugs. Electrospinning is a simple but versatile process that utilizes electrostatic forces to generate polymeric fibers and has been used for over 100 years to generate synthet…

Materials scienceamorphousoral drug deliveryPharmaceutical Sciencelcsh:RS1-44102 engineering and technologyReview030226 pharmacology & pharmacylcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicineamorphoucrystallineaqueous solubility enhancementDissolutionelectrospinningsolid dispersion021001 nanoscience & nanotechnologyElectrospinningAmorphous solidSynthetic fiberChemical engineeringPARTICLE SIZE REDUCTION0210 nano-technologyDispersion (chemistry)Oral retinoidSalt formation
researchProduct

Drug delivery of siRNA therapeutics

2020

Small interfering RNA (siRNA) is a class of nucleic acid-based drugs (NABDs) able to block gene expression by interaction with mRNA before its translation [...]

Messenger RNASmall interfering RNAChemistrysi-RNAlcsh:RS1-441Pharmaceutical ScienceTranslation (biology)Drug delivery; si-RNAlcsh:Pharmacy and materia medican/aEditorialDrug deliveryGene expressionDrug deliveryNucleic acidCancer research
researchProduct

A Setup for Microscopic Studies of Ultrasounds Effects on Microliters Scale Samples: Analytical, Numerical and Experimental Characterization

2021

International audience; Sonoporation is the process of cell membrane permeabilization, due to exposure to ultrasounds. There is a lack of consensus concerning the mechanisms of sonoporation: Understanding the mechanisms of sonoporation refines the choice of the ultrasonic parameters to be applied on the cells. Cells’ classical exposure systems to ultrasounds have several drawbacks, like the immersion of the cells in large volumes of liquid, the nonhomogeneous acoustic pressure in the large sample, and thus, the necessity for magnetic stirring to somehow homogenize the exposure of the cells. This article reports the development and characterization of a novel system allowing the exposure to …

MicroscopeMaterials scienceSonication[SDV]Life Sciences [q-bio]Pharmaceutical Science02 engineering and technologyultrasoundsArticlelaw.inventionnumerical simulations03 medical and health sciencesPharmacy and materia medicalawFluorescence microscopeFocal lengthsonoporation030304 developmental biology0303 health sciences021001 nanoscience & nanotechnologyCharacterization (materials science)RS1-441MicrobubblesUltrasonic sensor0210 nano-technologySonoporationBiomedical engineeringPharmaceutics
researchProduct

Naringenin Nano-Delivery Systems and Their Therapeutic Applications

2021

Naringenin (NRG) is a polyphenolic phytochemical belonging to the class of flavanones and is widely distributed in citrus fruits and some other fruits such as bergamot, tomatoes, cocoa, and cherries. NRG presents several interesting pharmacological properties, such as anti-cancer, anti-oxidant, and anti-inflammatory activities. However, the therapeutic potential of NRG is hampered due to its hydrophobic nature, which leads to poor bioavailability. Here, we review a wide range of nanocarriers that have been used as delivery systems for NRG, including polymeric nanoparticles, micelles, liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), nanosuspensions, and nano…

Naringeninnatural productsnaringeninlcsh:RS1-441Pharmaceutical ScienceReview02 engineering and technologyPharmacologylcsh:Pharmacy and materia medica03 medical and health scienceschemistry.chemical_compound0302 clinical medicineNutraceuticalSolid lipid nanoparticleflavonoidnutraceuticalsLiposomeChemistryfood and beverages021001 nanoscience & nanotechnologynanomedicineBioavailabilityantioxidants030220 oncology & carcinogenesisdrug deliveryDrug deliveryNanomedicinenanoparticlesNanocarriersbioavailability0210 nano-technologyPharmaceutics
researchProduct

Semi-Mechanistic Pharmacokinetic Model to Guide the Dose Selection of Nimotuzumab in Patients with Autosomal Dominant Polycystic Kidney Disease

2020

Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disease characterized by an overexpression of epidermal growth factor receptor (EGFR). Nimotuzumab is a recombinant humanized monoclonal antibody against human EGFR. The aim of this study was to develop a population pharmacokinetic model for nimotuzumab and to identify demographic and clinical predictive factors of the pharmacokinetic variability. The population pharmacokinetics (PopPK) of nimotuzumab was characterized using a nonlinear mixed-effect modeling approach with NONMEM&reg

Oncologymedicine.medical_specialtyEGFRPopulationAutosomal dominant polycystic kidney diseasePharmaceutical SciencePhases of clinical researchlcsh:RS1-441030226 pharmacology & pharmacyArticlesemi-mechanistic pharmacokineticslcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicinePharmacokineticsInternal medicinepopulation analysismedicinePolycystic kidney diseaseNimotuzumabEpidermal growth factor receptoreducationNONMEMeducation.field_of_studybiologyautosomal dominant polycystic kidney diseasebusiness.industrynimotuzumabmedicine.diseaseNONMEM030220 oncology & carcinogenesisbiology.proteinbusinessmedicine.drugPharmaceutics
researchProduct

Population Pharmacokinetics of Palbociclib in aReal-World Situation

2021

Palbociclib is an oral cyclin-dependent kinase inhibitor that is used in combination with aromatase inhibitors in the treatment of postmenopausal women with metastatic breast cancer. Its metabolism profile is associated with an important interpatient variability. We performed a population pharmacokinetics study of palbociclib in women routinely followed in a cancer center. One hundred and fifty-one samples were analyzed. The sampling times after administration ranged from 0.9 to 75 h and the samples were taken between 1 and 21 days after the beginning of the palbociclib cycle. Palbociclib was determined using a validated mass spectrometry method. The best model that described the concentrat…

Oncologymedicine.medical_specialtypalbociclibPharmaceutical ScienceRenal functionlcsh:Medicinelcsh:RS1-441Population pharmacokineticsAbsorption (skin)Palbociclib030226 pharmacology & pharmacyArticlelcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicineLag timepopulation pharmacokineticsInternal medicineDrug Discoverymedicinereal-world situationDosingPostmenopausal womenbusiness.industrylcsh:Rmedicine.diseaseMetastatic breast cancer030220 oncology & carcinogenesisMolecular MedicinebusinessPharmaceuticals
researchProduct

Network Pharmacology of Red Ginseng (Part I): Effects of Ginsenoside Rg5 at Physiological and Sub-Physiological Concentrations

2021

Numerous in vitro studies on isolated cells have been conducted to uncover the molecular mechanisms of action of Panax ginseng Meyer root extracts and purified ginsenosides. However, the concentrations of ginsenosides and the extracts used in these studies were much higher than those detected in pharmacokinetic studies in humans and animals orally administered with ginseng preparations at therapeutic doses. Our study aimed to assess: (a) the effects of ginsenoside Rg5, the major “rare” ginsenoside of Red Ginseng, on gene expression in the murine neuronal cell line HT22 in a wide range of concentrations, from 10−4 to 10−18 M, and (b) the effects of differentially expressed genes on cellular …

Pharmaceutical SciencePharmacologyArticlepharmacology_toxicologyTranscriptomechemistry.chemical_compoundGinsengtranscriptomicsPharmacy and materia medicaDrug DiscoveryGene expressionnetwork pharmacologyred ginsengRIn vitroRS1-441Gene expression profilingIPA pathwayschemistryGinsenosideApoptosisCell cultureginsenoside Rg5gene expressionMedicineMolecular MedicinePharmaceuticals
researchProduct